Broad-spectrum bioactivities of silver nanoparticles: The emerging trends and future prospects

Applied Microbiology and Biotechnology

Volumn 98, Issue 5, 2014, Pages 1951-1961

  Rai, Mahendra ^a,d   Kon, Kateryna ^b   Ingle, Avinash ^a   Duran, Nelson ^c,d   Galdiero, Stefania ^e   Galdiero, Massimiliano ^e  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

^b KHARKIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antiarthropod; Anticancer; Antimicrobial; Bioactivity; Silver nanoparticles

Indexed keywords

ANTIARTHROPOD; ANTICANCER; ANTICANCER ACTIVITIES; ANTICANCER POTENTIALS; ANTIMICROBIAL; MULTIFUNCTIONAL ACTIVITY; SILVER NANOPARTICLES; THERAPEUTIC POTENTIALS;

BIOACTIVITY; DIAGNOSIS; MEDICAL NANOTECHNOLOGY; MICROORGANISMS; NANOPARTICLES;

SILVER;

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CURCUMIN; ERYTHROMYCIN; FLUCONAZOLE; GENTAMICIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HYDRAZIDE; METICILLIN; NATAMYCIN; PHTHALAZINE DERIVATIVE; PLANT EXTRACT; PODOPHYLLUM HEXANDRUM EXTRACT; PYRIDAZINE DERIVATIVE; SESBANIA GRANDIFLORA EXTRACT; SILVER NANOPARTICLE; STREPTOMYCIN; TETRACYCLINE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG; VITEX NEGUNDO EXTRACT;

ANTIMICROBIAL ACTIVITY; BIOACTIVITY; CANCER; FUTURE PROSPECT; GROWTH RATE; NANOTECHNOLOGY; SILVER; TUMOR;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; CANCER THERAPY; CYTOTOXICITY; DIAGNOSTIC TEST; HUMAN; INFECTION CONTROL; NANOMEDICINE; NONHUMAN; REVIEW;

ANTINEOPLASTIC AGENTS; DISINFECTANTS; INSECTICIDES; NANOPARTICLES; SILVER;

EID: 84896724681     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-5473-x     Document Type: Review

References (101)

1. Abebe L (2012) Silver impregnated ceramic water filters to treat Cryptosporidium parvum. CGH Symposium, 1 October 2012. http://prezi.com/fx-3- 9w4ai0h/silver-nanoparticle-treated-cryptosporidium-parvum-response-in-mice/. Accessed 26 March 2013
2. Abraham I, El-Sayed K, Chen ZS, Guo H (2012) Current status on marine products with reversal effect on cancer multidrug resistance. Mar Drugs 10:2312-2321
3. Adhikari U, Ghosh A, Chandra G (2013) Nanoparticles of herbal origin: a recent eco-friend trend in mosquito control. Asian Pac J Trop Dis 3:167-168
4. 2)O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol 6:933-940
5. Allahverdiyev AM, Abamor ES, Bagirova M, Ustundag CB, Kaya C, Kaya F, Rafailovich M (2011b) Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomedicine 6:2705-2714
6. Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M (2011c) Coping with antibiotic resistance: combination of nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti-Infect Ther 9:1035-1052
7. Banerjee M, Mallick S, Paul A, Chattopadhyay A, Ghosh SS (2010) Heightened reactive oxygen species generation in the antimicrobial activity of a three component iodinated chitosan-silver nanoparticle composite. Langmuir 26:5901-5908
8. Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R (2009) Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 20:1497-1502
9. Bawaskar M, Gaikwad S, Ingle A, Rathod D, Gade A, Duran N, Marcato PD, Rai M (2010) A new report on mycosynthesis of silver nanoparticles by Fusarium culmorum. Curr Nanosci 6:376-380
10. Bhattacharyya SS, Das J, Das S, Samadder A, Das D, De A, Paul S, Khuda-Bukhsh AR (2012) Rapid green synthesis of silver nanoparticles from silver nitrate by a homeopathic mother tincture phytolacca decandra. Zhong Xi Yi Jie He Xue Bao 10:546-554
11. Birla SS, Tiwari VV, Gade AK, Ingle AP, Yadav AP, Rai MK (2009) Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol 48:173-179
12. Bonde SR, Rathod DP, Ingle AP, Ade RB, Gade AK, Rai MK (2012) Murraya koenigii-mediated synthesis of silver nanoparticles and its activity against three human pathogenic bacteria. Nanosci Meth 1:25-36
13. Conde J, Doria G, Baptista P (2012) Noble metal nanoparticles applications in cancer. J Drug Deliv 751075:1-12
14. Dar MA, Ingle A, Rai M (2013) Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics. Nanomedicine NBM 9:105-110
15. De-Gusseme B, Sintubin L, Baert L, Thibo E, Hennebel T, Vermeulen G, Uyttendaele M, Verstraete W, Boon N (2010) Biogenic silver for disinfection of water contaminated with viruses. Appl Environ Microbiol 76:1082-1087
16. De-Lima R, Seabra AB, Durán N (2012) Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol 32:867-879
17. De-Lima R, Feitosa LO, Ballottin D, Marcato PD, Tasic L, Durán N (2013) Cytotoxicity and genotoxicity of biogenic silver nanoparticles. J Phys Conf Series 429:012020
18. Devi LS, Joshi SR (2012) Antimicrobial and synergistic effects of silver nanoparticles synthesized using soil fungi of high altitudes of Eastern Himalaya. Mycobiol 40:27-34
19. Duran N, Marcato PD (2013) Nanobiotechnology perspectives: role of nanotechnology in the food industry: a review. Int J Food Sci Technol 48:1127-1134
20. Duran N, Marcato PD, Teixeira Z, Durán M, Costa FTM, Brocchi M (2009) State of the art of nanobiotechnology applications in neglected diseases. Curr Nanosci 5:396-408
21. Duran N, Marcato PD, De-Conti R, Alves OL, Costa FTM, Brocchi M (2010) Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc 21:949-959
22. Durand R, Bouvresse S, Berdjane Z, Izri A, Chosidow O, Clark JM (2012) Insecticide resistance in head lice: clinical, parasitological and genetic aspects. Clin Microbiol Infect 18:338-344
23. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ (2005) Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 3:6
24. Elliott C (2010) The effects of silver dressings on chronic and burns wound healing. Br J Nurs 19:S32-S36
25. Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, Diémé Y, Briolant S, Bercion R, Wade B, Tall A, Pradines B (2013) Plasmodium falciparum susceptibility to antimalarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J 12:107
26. Fayaz AM, Ao Z, Girilal M, Chen L, Xiao X, Kalaichelvan P, Yao X (2012) Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection. Int J Nanomedicine 7:5007-5018
27. Gade A, Gaikwad S, Tiwari V, Yadav A, Ingle A, Rai M (2010) Biofabrication of silver nanoparticles by Opuntia ficus-indica: in vitro antibacterial activity and study of the mechanism involved in the synthesis. Curr Nanosci 6:370-375
28. Gaikwad S, Ingle A, Gade A, Rai M, Falanga A, Incoronato N, Russo L, Aldiero S, Galdiero M (2013) Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomedicine 3(8):4303-4314
29. Gajbhiye MB, Kesharwani JG, Ingle AP, Gade AK, Rai MK (2009) Fungus mediated synthesis of silver nanoparticles and its activity against pathogenic fungi in combination of fluconazole. Nanomedicine NBM 5:282-286
30. Galdiero S, Falanga A, Vitiello M, Marra MCV, Galdiero M (2011) Silver nanoparticles as potential antiviral agents molecules. Molecules 16:8894-8918
31. Galdiero S, Falanga A, Cantisani M, Ingle A, Galdiero M, Rai M (2014) Silver nanoparticles as novel antibacterial and antiviral agents, In: Frontiers of Nanomedical Research, Worlds Scientific Publishing 2014, in press
32. Howard CR, Fletcher NF (2012) Emerging virus diseases: can we ever expect the unexpected? Emerg Microbes Infect 1:e46
33. Ingle A, Gade A, Pierrat S, Sonnichsen C, Rai M (2008) Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci 4:141-144 (Pubitemid 352024782)
34. Ingle A, Rai M, Gade G, Bawaskar M (2009) Fusarium solani: a novel biological agent for the extracellular synthesis of silver nanoparticles. J Nanopart Res 11:2079-2085
35. Jacob SJP, Finu JS, Narayanan A (2012) Synthesis of silver nanoparticles using Piper longum leaf extracts and its cytotoxic activity against Hep-2 cell line. Colloids Surf B: Biointerfaces 91:212-214
36. Jaidev LR, Narasimha G (2010) Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity. Colloids Surf B: Biointerfaces 81:430-433
37. Jain KK (2010) Advances in the field of nano-oncology. BMC Med 8:1-11
38. Jayaseelan C, Rahuman AA (2012) Acaricidal efficacy of synthesized silver nanoparticles using aqueous leaf extract of Ocimum canum against Hyalomma anatolicum anatolicum and Hyalomma marginatum isaaci (Acari: Ixodidae). Parasitol Res 111:1369-1378
39. Jayaseelan C, Rahuman AA, Rajakumar G, Santhoshkumar T, Kirthi AV, Marimuthu S, Bagavan A, Kamaraj C, Zahir AA, Elango G, Velayutham K, Rao KV, Karthik L, Raveendran S (2012) Efficacy of plant-mediated synthesized silver nanoparticles against hematophagous parasites. Parasitol Res 111:921-933
40. Jeyaraj M, Rajesh M, Arun R, MubarakAli D, Sathishkumar G, Sivanandhan G, Dev KG, Manickavasagam M, Premkumar K, Thajuddin N, Ganapathi A (2013a) An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles using Podophyllum hexandrum on human cervical carcinoma cells. Colloids Surf B: Biointerfaces 102:708-717
41. Jeyaraj M, Sathishkumar G, Sivanandhan G, Mubarak-Ali D, Rajesh M, Arun R, Apildev G, Manickavasagam M, Thajuddin N, Premkumar K, Ganapathi A (2013b) Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B: Biointerfaces 106:86-92
42. Jo YK, Kim BH, Jung G (2009) Antifungal activity of silver ions and nanoparticles on phytopathogenic fungi. Plant Dis 93:1037-1043
43. Johnson AP (2011) Methicillin resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 66:iv43-iv48
44. Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman DD (2013) Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med 21:6-14
45. Kamareddine L (2012) The biological control of the malaria vector. Toxins (Basel) 4:748-767
46. Kandile NG, Zaky HT, Mohamed MI, Mohamed HM (2010) Silver nanoparticles effect on antimicrobial and antifungal activity of new heterocycles. Bull Kor Chem Soc 31:3530-3538
47. Kaur P, Thakur R, Choudhary A (2012) An in vitro study of the antifungal activity of silver/chitosan nanoformulations against important seed borne pathogens. Int J Sci Technol Res 1:83-86
48. Kilpatrick AM, Randolph SE (2012) Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet 380:1946-1955
49. Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG (2008) Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol 18:1482-1484
50. Kim KJ, Sung WS, Suh BK, Moon SK, Choi JS, Kim JG, Lee DG (2009) Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 22:235-242
51. Korich DG, Mead JR, Madore MS, Sinclair NA, Sterling CR (1990) Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability. Appl Environ Microbiol 56:1423-1428 (Pubitemid 20147225)
52. Lara HH, Ayala-Nunez NV, Ixtepan-Turrent L, Rodriguez-Padilla C (2010a) Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol 8:1
53. Lara HH, Ixtepan-Turrent L, Garza-Treviño EN, Rodriguez-Padilla C (2010b) PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J Nanobiotechnol 8:15-25
54. Lara HH, Ixtepan-Turrent L, Garza-Treviño EN, Singh DK (2011) Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins. J Nanobiotechnol 9:38
55. Liu HL, Dai SA, Fu KY, Hsu SH (2010) Antibacterial properties of silver nanoparticles in three different sizes and their nanocomposites with a new waterborne polyurethane. Int J Nanomedicine 5:1017-1028
56. Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK, Che CM (2008) Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13:253-262
57. Marr AK, McGwire BS, McMaster WR (2012) Modes of action of leishmanicidal antimicrobial peptides. Future Microbiol 7:1047-1059
58. Marsich E, Travan A, Donati I, Turco G, Kulkova J, Moritz N, Aro HT, Crosera M, Paoletti S (2013) Biological responses of silver-coated thermosets: an in vitro and in vivo study. Acta Biomater 9:5088-5099
59. Mehrbod P, Motamed N, Tabatabaian M, Soleimani ER, Amini E, Shahidi M, Kheiri MT (2009) In vitro antiviral effect of "nanosilver" on influenza virus. DARU 17:88-93
60. Misra R, Acharya S, Sahoo SK (2010) Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today 15:842-850
61. Mohebali M, Rezayat MM, Gilani K, Sarkar S, Akhoundi B, Esmaeili J, Satvat T, Elikaee S, Charehdar S, Hooshyar H (2009) Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study. DARU J Pharm Sci 17:285-289
62. Murray HW (1981) Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med 153:1302-1315
63. Murugan K, Shri KP, Barnard D (2013) Green synthesis of silver nanoparticles from botanical sources and their use for control of medical insects and malaria parasites. http://www.ars.usda.gov/research/publications/ publications.htm?seq-no-115=281989. Accessed 26 March 2013
64. Narasimha G (2012) Antiviral activity of silver nanoparticles synthesized by fungal strain Aspergillus niger. J Nanosci Nanotechnol 6(1):18-20
65. Nasrollahi A, Pourshamsian K, Mansourkiaee P (2011) Antifungal activity of silver nanoparticles on some of fungi. Int J Nanotechnol 1:233-239
66. Nilforoushzadeh MA, Shirani-Bidabadi LA, Zolfaghari-Baghbaderani A, Jafari R, Heidari-Beni M, Siadat A, Ghahraman-Tabrizi M (2012) Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in balb/c mice. J Vector Borne Dis 49:249-253
67. Pal S, Tak UK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712-1720 (Pubitemid 46449051)
68. Panneerselvam C, Ponarulselvam S, Murugan K (2011) Potential antiplasmodial activity of synthesized silver nanoparticle using Andrographis paniculata nees (Acanthaceae). Archives of Applied Science Research 3(6):208-217
69. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi YJ, Choi J, Hyun JW (2011) Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92-100
70. Ponarulselvam S, Panneerselvam C, Murugan K, Aarthi N, Kalimuthu K, Thangamani S (2012) Synthesis of silver nanoparticles using leaves of Catharanthus roseus Linn. G. Don and their antiplasmodial activities. Asian Pac J Trop Biomed 2:574-580
71. Prabhu D, Arulvasu C, Babu G, Manikandan R, Srinivasan P (2013) Biologically synthesized green silver nanoparticles from leaf extract of Vitex negundo L. induce growth-inhibitory effect on human colon cancer cell line HCT15. Process Biochem 48:317-324
72. Qiao W, Wang B, Wang Y, Yang L, Zhang Y, Shao P (2010) Cancer therapy based on nanomaterials and nanocarrier systems. J Nanomater 796303:1-9
73. Raghavendra K, Barik TK, Reddy BP, Sharma P, Dash AP (2011) Malaria vector control: from past to future. Parasitol Res 108:757-779
74. Raheman F, Deshmukh S, Ingle A, Gade A, Rai M (2011) Silver nanoparticles: novel antimicrobial agent synthesized from an endophytic fungus Pestalotia sp. isolated from leaves of Syzygium cumini (L). Nano Biomed Eng 3(3):174-178
75. Rai M, Ingle A (2012) Role of nanotechnology in agriculture with special reference to management of insect pests. Appl Microbiol Biotechnol 94:287-293
76. Rai MK, Yadav AP, Gade AK (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76-82
77. Rai M, Gade A, Gaikwad S, Marcato PD, Durán N (2012) Biomedical applications of nanobiosensors: the state-of-the-art. J Braz Chem Soc 23:14-24
78. Rigo C, Ferroni L, Tocco I, Roman M, Munivrana I, Gardin C, Cairns WR, Vindigni V, Azzena B, Barbante C, Zavan B (2013) Active silver nanoparticles for wound healing. Int J Mol Sci 14:4817-4840
79. Roger JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM (2008) A Preliminary assessment of silver nanoparticle inhibition of monkeypox virus plciue formation. Nanoscale Res Lett 3:129-133
80. Rossi-Bergmann B, Pacienza-Lima W, Marcato PD, De-Conti R, Durán N (2012) Therapeutic potential of biogenic silver nanoparticles in murine cutaneous leishmaniasis. J Nano Res 20:89-97
81. Said DE, Elsamad LM, Gohar YM (2012) Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Parasitol Res 111:545-554
82. Salem ANB, Zyed R, Lassoued MA, Nidhal S, Sfar S, Mahjoub A (2012) Plant-derived nanoparticles enhance antiviral activity against coxsakievirus B3 by acting on virus particles and vero cells. Dig J Nanomater Biostruct 7:737-744
83. Salunkhe RB, Patil SV, Patil CD, Salunke BK (2011) Larvicidal potential of silver nanoparticles synthesized using fungus Cochliobolus lunatus against Aedes aegypti (Linnaeus, 1762) and Anopheles stephensi Liston (Diptera; Culicidae). Parasitol Res 109:823-831
84. Satyavani K, Gurudeeban S, Ramanathan T, Balasubramanian T (2012) Toxicity study of silver nanoparticles synthesized from Suaeda monoica on Hep-2 cell line. Avicenna J Med Biotech 4:35-39
85. Savithramma N, Rao ML, Rukmini K, Suvarnalatha-Devi P (2011) Antimicrobial activity of silver nanoparticles synthesized by using medicinal plants. Int J Chem Technol Res 3:1394-1402
86. Seigneuric R, Markey L, Nuyten DSA, Dubernet C, Evelo CTA, Finot E, Garrido C (2010) From nanotechnology to nanomedicine: applications to cancer research. Curr Mol Med 10:640-652
87. Shameli K, Ahmad MB, Jazayeri SD, Shabanzadeh P, Sangpour P, Jahangirian H, Gharayebi Y (2012) Investigation of antibacterial properties silver nanoparticles prepared via green method. Chem Central J 6:73
88. Shio MT, Olivier M (2010) Editorial: Leishmania survival mechanisms: the role of host phosphatases. J Leukoc Biol 88:1-3
89. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as amodel for gram-negative bacteria. J Colloid Interface Sci 275:177-182 (Pubitemid 38670216)
90. Speshock JL, Murdock RC, Braydich-Stolle LK, Schrand AM, Hussain SM (2010) Interaction of silver nanoparticles with tacaribe virus. J Nanobiotechnol 8:19
91. Sriram MI, Barath S, Kanth M, Kalishwaralal K, Gurunathan S (2010) Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Int J Nanomed 5:753-762
92. Su YH, Varhue W, Liao KT, Swami N (2012) Characterizing silver nanoparticle-induced modifications to the dielectric response of Cryptosporidia oocysts. Annual Meeting of the American Electrophoresis Society (AES)
93. Subarani S, Sabhanayakam S, Kamaraj C (2013) Studies on the impact of biosynthesized silver nanoparticles (AgNPs) in relation to malaria and filariasis vector control against Anopheles stephensi liston and Culex quinquefasciatus Say (Diptera: Culicidae). Parasitol Res 112:487-499
94. Sun RW, Chen R, Chung NP, Ho CM, Lin CL, Che CM (2005) Silver nanoparticles fabricated in hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun 40:5059-5061 (Pubitemid 41566432)
95. Sun L, Singh AK, Vig K, Pillai SR, Singh SR (2008) Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol 4:149-158
96. Tile VA, Bholay AD (2012) Biosynthesis of silver nanoparticles and its antifungal activities. J Environ Res Develop 7:338-345
97. Trefry JC, Wooley DP (2013) Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J Biomed Nanotech 9:1624-1635
98. Xiang DX, Chen Q, Pang L, Zheng CL (2011) Inhibitory effects of silver nanoparticles on H1N1 influenza a virus in vitro. J Virol Methods 178:137-142
99. Xu Y, Gao C, Li X, He Y, Zhou L, Pang G, Sun S (2013) In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi. J Ocul Pharmacol Ther 29:270-274
100. Zhang H, Smith JA, Oyanedel-Craver V (2012) The effect of natural water conditions on the anti-bacterial performance and stability of silver nanoparticles capped with different polymers. Water Res 46:691-699
101. Zhang K, Li F, Imazato S, Cheng L, Liu H, Arola DD, Bai Y, Xu HH (2013) Dual antibacterial agents of nano-silver and 12-methacryloyloxydodecylpyridinium bromide in dental adhesive to inhibit caries. J Biomed Mater Res B Appl Biomater 101:929-938